Also, our data suggests that both MV4-11 and in MOLM-14, another FLT3-mutated AML cell line, have similar phenotypes (blast regrowth) and molecular characterizations (increased pBAD) existing after TKI-treatment during the time-course studies (Supplementary Figures 1C, D). Here, FLT3 is linked to acute myeloid leukemia.